These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 5611695)

  • 1. [Cocarboxylase treatment of patients with ischemic heart disease and several other diseases].
    Egorov MN; Nozdriukhina LR; Pastukhova NP; Zhuravleva VI; Pisarskaia IV
    Ter Arkh; 1967 Feb; 39(2):91-3. PubMed ID: 5611695
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the use of an association of ATP, cocarboxylase and beta-hydroxy-propyl-theobromine in cardiovascular therapy].
    Alberto S; Brusasco L; Colongo PG
    Minerva Cardioangiol; 1966 Sep; 14(9):557-63. PubMed ID: 5991009
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experience in treating patients with chronic coronary insufficiency with cocarboxylase in a polyclinic].
    Kuz'mina EN
    Sov Med; 1971; 34(12):111-3. PubMed ID: 5148404
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of meteorologic pathological reactions in patients with ischemic heart disease and neurocirculatory asthenia].
    Revutskiĭ EL; Nikberg II; Novikova TG; Fedorishko SS
    Vrach Delo; 1988 Feb; (2):7-10. PubMed ID: 3381526
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical data on the use of an association of adenosine-5-monophosphoric acid, cocarboxylase and vitamin B 12 as coadjuvants in the treatment of senile myocardiopathies].
    Alberto S; Brusasco L; Colongo PG
    Clin Ter; 1966 Jun; 37(6):519-38. PubMed ID: 5989918
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of a compound of adenosine triphosphate (ATP), cocarboxylase and beta-hydroxypropyl-theobromine in cardiovascular therapy.
    Alberto S; Brusasco L; Colongo PG
    Panminerva Med; 1966 Oct; 8(10):390-7. PubMed ID: 5977157
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of coenzymes on the systole-diastolic function of the myocardium in patients with cardiac insufficiency].
    Bakumenko MS; Savchenkov II; Bol'shakova EA
    Ter Arkh; 1973 Jan; 45(1):79-84. PubMed ID: 4770027
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of a new psychopharmacological agent in cardiology].
    Ryba D; Halpern S
    Minerva Cardioangiol; 1971 Mar; 19(3):172-7. PubMed ID: 5573133
    [No Abstract]   [Full Text] [Related]  

  • 9. [Characteristics of the course of myocardial infarct under the effects of cocarboxylase (clinico-experimental study)].
    Filatova MI
    Ter Arkh; 1971 Nov; 43(11):34-7. PubMed ID: 5149222
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of cocarboxylase on myocardial contractile function and hemodynamics of the lesser circulation in patients with myocardial infarct].
    Korolenko AB
    Vrach Delo; 1971 Nov; 11():8-11. PubMed ID: 5143292
    [No Abstract]   [Full Text] [Related]  

  • 11. [Influence of cocarboxylase on arrhythmias in acute myocardial infarct].
    BENDA L; DONEFF D; MOSER K
    Cardiologia (Basel); 1959; 34(5):298-309. PubMed ID: 13652137
    [No Abstract]   [Full Text] [Related]  

  • 12. The cocarboxylase content of blood in normal subjects and in various diseases, especially neurocirculatory asthenia.
    VARTIO TJ
    Scand J Clin Lab Invest; 1953; 5 Suppl. 10():1-60. PubMed ID: 13168253
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experience concerning the therapeutic action of combined adenosine monophosphoric acid, cocarboxylase, and vitamin B 12 in geriatric medicine].
    Barbieri R; Michetti A
    Minerva Med; 1967 Mar; 58(21):899-906. PubMed ID: 6026544
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of cocarboxylase in the complex treatment of patients with Botkin's disease].
    Korobko AP
    Vrach Delo; 1973 Feb; 2():150-3. PubMed ID: 4722318
    [No Abstract]   [Full Text] [Related]  

  • 15. [The efficacy of Eleutherococcus and cralonin in the sanatorium-health resort treatment of patients with ischemic heart disease and neurocirculatory dystonia].
    Garkavi LKh; Shepelev AP; Tatkov OV; Mar'ianovskiĭ AA
    Voen Med Zh; 2000 Sep; 321(9):42-7. PubMed ID: 11077531
    [No Abstract]   [Full Text] [Related]  

  • 16. [Carbohydrate metabolism disorder in ischemic cardiopathies].
    Kleinerman L; Apetrei E; Iliescu M; Cionca H; Constantinescu S; Zătreanu Y
    Med Interna (Bucur); 1970 Sep; 22(9):1071-8. PubMed ID: 5491376
    [No Abstract]   [Full Text] [Related]  

  • 17. [Suloctidil (sulocton) in the treatment of atherosclerotic neurasthenic syndromes].
    Prusiński A; Kotwica S; Niewodniczy A; Split W
    Wiad Lek; 1982 May; 35(3-4):201-5. PubMed ID: 6287740
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the effectiveness of cocarboxylase in the treatment of patients with coronarocardiosclerosis].
    Belen'kiĭ AI
    Kardiologiia; 1969 Apr; 9(4):130-3. PubMed ID: 5803351
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of cocarboxylase on various types of heart rhythm disorders].
    Bazhenova SN; Liutrovnik BV
    Klin Med (Mosk); 1968 Jun; 46(6):90-4. PubMed ID: 5710582
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnostic and evaluative aspects of pseudo-ischemic electrocardiographic patterns in adult subjects].
    Di Benedetto A; Frada G
    Lav Um; 1972 Nov; 24(6 Suppl):11-21. PubMed ID: 4680390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.